Rapid Release of Matrix Metalloproteinase (MMP)-2 by Thrombin in the Rat Aorta: Modulation by Protein Tyrosine Kinase/Phosphatase

Summary

Matrix metalloproteinase-2 (MMP-2, gelatinase A) and thrombin contribute to many long-term (patho)physiological processes requiring the proteolytic breakdown of the vascular extracellular matrix (e.g., normal tissue repair, remodeling, tumor invasion, atherosclerosis plaque rupture). Thrombin (10 to 1000 nM, 0.5 to 50 U/ml) induced a rapid secretion of MMP-2 from freshly isolated rat aortic tissue (detectable after 1 min of thrombin exposure). This secretion was mediated by an unidentified thrombin receptor, distinct from the proteinase activated receptors (PAR)-1 and -2. Protein tyrosine kinase/phosphatase activity differentially modulated the basal and the thrombin-induced release of MMP-2. The inhibitors of protein tyrosine kinase, herbymicin A, genistein, and tyrphostin 1288 (1 to 100 μM), enhanced the basal release of MMP-2 but did not affect the thrombin-induced secretion of MMP-2. The inhibitor of phosphotyrosine phosphatases, vanadate (100 μM), selectively inhibited the thrombin-induced, but not the basal, release of MMP-2. Rapid release of vascular MMP-2 by thrombin could contribute to short-term processes where thrombin is involved such as the regulation of platelet aggregation and vascular reactivity. Vascular tyrosine kinase/phosphatase likely modulates this action of thrombin to prevent exaggerated platelet aggregation, thrombosis, and vasospasm.

• References

• 1 Southgate KM, Davies M, Booth RF, Newby AC. Involvement of extracellular matrix degrading metalloproteinases in rabbit aortic smooth muscle cell proliferation. Biochem J 1992; 288: 93-9.
• 2 Ray JM, Stetler-Stevenson WG. The role of metalloproteinases and their inhibitors in tumor, metastasis, and angiogenesis. Eur Respir J 1994; 7: 2062-72.
• 3 Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opinion in Cell Biol 1995; 7: 728-35.
• 4 Yu AE, Murphy AN, Stetler-Stevenson WG. 72-kDa gelatinase (gelatinase A): Structure, activation, regulation and substrate specificity. In: Matrix metalloproteinases. Parks WC, Mecham RP. eds. Academic Press; San Diego, London: 1998: 85-113.
• 5 Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994; 370: 61-5.
• 6 Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Plasma membrane-dependent activation of 72-kDa Type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 1995; 270: 5331-8.
• 7 Gianelli G, Falk-Marzillier J, Shiraldi O, Stetler-Stevenson W, Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997; 277: 225-8.
• 8 Sawicki G, Salas E, Murat J, Miszta-Lane H, Radomski MW. Release of gelatinase A during platelet activation mediates aggregation. Nature 1997; 386: 616-9.
• 9 Sawicki G, Sanders EJ, Salas E, Wozniak M, Rodrigo J, Radomski MW. Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost 1998; 80: 836-9.
• 10 Fernandez-Patron C, Martinez-Cuesta MA, Salas E, Sawicki G, Wozniak M, Radomski MW, Davidge ST. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb Haemost 1999; 82 (in press)
• 11 Yang Z, Arnet U, Bauer E, von Segesser L, Siebenmann R, Turina M, Luescher TF. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide and thromboxane A2. Circulation 1994; 89: 2266-72.
• 12 Li Z, Froehlich J, Galis ZS, Lakatta EG. Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension 1999; 33: 116-23.
• 13 Zucker S, Conner C, DiMassimo BL, Howard E, Drews M, Seiki M, Bahou WF. Thrombin induces the activation of pro-gelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis. J Biol Chem 1995; 270: 23730-8.
• 14 Vu T-H, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
• 15 Hollenberg MD, Saifeddine M, Al-Ani B, Kawabata A. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol 1997; 75: 832-41.
• 16 Saifeddine M, Al-Ani B, Cheng A-H, Wang L, Hollenberg MD. Rat proteinase-activated receptor-2 (PAR-2): c-DNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Brit J Pharmacol 1996; 118: 521-30.
• 17 Galis ZS, Kranzhoefer R, Fenton II JW, Libby P. Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Atherioscl Thromb Vasc Biol 1997; 17: 483-9.
• 18 Jerius H, Beall A, Woodrum D, Epstein A, Brophy C. Thrombin-induced vasospasm: cellular signaling mechanisms. Surgery 1998; 123: 46-50.